Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sujay Srinivas

Showing results (41-50 of 47) with videos related to

Pageof 5
Sort By:
You have reached the last page of results.This site can display upto 47 results.
HPB : the Official Journal of the International Hepato Pancreato Biliary Association|July 17, 2024
Adjuvant therapy may improve overall survival in high-risk periampullary adenocarcinomas patients - A match-pair analysis from a multi-institutional cohort study (The MIPPAP study)Anant Ramaswamy, Vikram Chaudhari, Sujay Srinivas, et al.
Cancer Medicine|October 31, 2020
COVID-19 in cancer patients on active systemic therapy - Outcomes from LMIC scenario with an emphasis on need for active treatmentAnant Ramaswamy, Lingaraj Nayak, Nirmalya Roy Moulik, et al.
Frontiers in Oncology|September 27, 2021
Demographics, Pattern of Care, and Outcome Analysis of Malignant Melanomas - Experience From a Tertiary Cancer Centre in IndiaJyoti Bajpai, George Abraham, Avanish P Saklani, et al.
JNCI Cancer Spectrum|July 27, 2024
Docetaxel-oxaliplatin-capecitabine/5-fluorouracil (DOX/F) followed by docetaxel versus oxaliplatin-capecitabine/5-fluorouracil (CAPOX/FOLFOX) in HER2-negative advanced gastric cancersAnant Ramaswamy, Prabhat Bhargava, Biswajit Dubashi, et al.
South Asian Journal of Cancer|December 22, 2025
Consensus Statements for Clinical Practice in Advanced/Metastatic Colorectal Cancers in India Using a Modified Delphi MethodAnant Ramaswamy, Sujay Srinivas, Viraj Lavingia, et al.
Cancer|June 1, 2019
A randomized phase 3 trial comparing nimotuzumab plus cisplatin chemoradiotherapy versus cisplatin chemoradiotherapy alone in locally advanced head and neck cancerVijay Maruti Patil, Vanita Noronha, Amit Joshi, et al.
European Journal of Cancer (Oxford, England : 1990)|February 2, 2024
Phase 3 RCT comparing docetaxel-platinum with docetaxel-platinum-5FU as neoadjuvant chemotherapy in borderline resectable oral cancerVanita Noronha, Vijay Patil, Pankaj Chaturvedi, et al.
Pageof 5

Showing results (41-50 of 47) with videos related to

Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 47 results.
HPB : the Official Journal of the International Hepato Pancreato Biliary Association|July 17, 2024
Adjuvant therapy may improve overall survival in high-risk periampullary adenocarcinomas patients - A match-pair analysis from a multi-institutional cohort study (The MIPPAP study)Anant Ramaswamy, Vikram Chaudhari, Sujay Srinivas, et al.
Cancer Medicine|October 31, 2020
COVID-19 in cancer patients on active systemic therapy - Outcomes from LMIC scenario with an emphasis on need for active treatmentAnant Ramaswamy, Lingaraj Nayak, Nirmalya Roy Moulik, et al.
Frontiers in Oncology|September 27, 2021
Demographics, Pattern of Care, and Outcome Analysis of Malignant Melanomas - Experience From a Tertiary Cancer Centre in IndiaJyoti Bajpai, George Abraham, Avanish P Saklani, et al.
JNCI Cancer Spectrum|July 27, 2024
Docetaxel-oxaliplatin-capecitabine/5-fluorouracil (DOX/F) followed by docetaxel versus oxaliplatin-capecitabine/5-fluorouracil (CAPOX/FOLFOX) in HER2-negative advanced gastric cancersAnant Ramaswamy, Prabhat Bhargava, Biswajit Dubashi, et al.
South Asian Journal of Cancer|December 22, 2025
Consensus Statements for Clinical Practice in Advanced/Metastatic Colorectal Cancers in India Using a Modified Delphi MethodAnant Ramaswamy, Sujay Srinivas, Viraj Lavingia, et al.
Cancer|June 1, 2019
A randomized phase 3 trial comparing nimotuzumab plus cisplatin chemoradiotherapy versus cisplatin chemoradiotherapy alone in locally advanced head and neck cancerVijay Maruti Patil, Vanita Noronha, Amit Joshi, et al.
European Journal of Cancer (Oxford, England : 1990)|February 2, 2024
Phase 3 RCT comparing docetaxel-platinum with docetaxel-platinum-5FU as neoadjuvant chemotherapy in borderline resectable oral cancerVanita Noronha, Vijay Patil, Pankaj Chaturvedi, et al.
Pageof 5